Loomis, Sayles & Company’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-16,569
| Closed | -$835K | – | 907 |
|
|
2018
Q2 | $835K | Sell |
16,569
-6,933
| -29% | -$349K | ﹤0.01% | 557 |
|
|
2018
Q1 | $1.15M | Sell |
23,502
-500
| -2% | -$24.4K | ﹤0.01% | 565 |
|
|
2017
Q4 | $1.06M | Hold |
24,002
| – | – | ﹤0.01% | 559 |
|
|
2017
Q3 | $1.22M | Hold |
24,002
| – | – | ﹤0.01% | 557 |
|
|
2017
Q2 | $1.29M | Hold |
24,002
| – | – | ﹤0.01% | 552 |
|
|
2017
Q1 | $1.27M | Sell |
24,002
-1,129
| -4% | -$59.5K | ﹤0.01% | 559 |
|
|
2016
Q4 | $1.21M | Buy |
25,131
+4,839
| +24% | +$233K | ﹤0.01% | 587 |
|
|
2016
Q3 | $1.09M | Buy |
20,292
+1,669
| +9% | +$90K | ﹤0.01% | 580 |
|
|
2016
Q2 | $1.01M | Buy |
18,623
+2,118
| +13% | +$115K | ﹤0.01% | 570 |
|
|
2016
Q1 | $837K | Buy |
16,505
+6,231
| +61% | +$316K | ﹤0.01% | 589 |
|
|
2015
Q4 | $518K | Buy |
10,274
+1,519
| +17% | +$76.6K | ﹤0.01% | 619 |
|
|
2015
Q3 | $421K | Buy |
8,755
+592
| +7% | +$28.5K | ﹤0.01% | 638 |
|
|
2015
Q2 | $425K | Sell |
8,163
-2,736
| -25% | -$142K | ﹤0.01% | 615 |
|
|
2015
Q1 | $629K | Buy |
10,899
+233
| +2% | +$13.4K | ﹤0.01% | 622 |
|
|
2014
Q4 | $570K | Sell |
10,666
-108,296
| -91% | -$5.79M | ﹤0.01% | 595 |
|
|
2014
Q3 | $6.84M | Buy |
118,962
+77,415
| +186% | +$4.45M | 0.02% | 522 |
|
|
2014
Q2 | $2.78M | Sell |
41,547
-236
| -0.6% | -$15.8K | 0.01% | 566 |
|
|
2014
Q1 | $2.79M | Buy |
41,783
+481
| +1% | +$32.1K | 0.01% | 559 |
|
|
2013
Q4 | $2.76M | Buy |
41,302
+15,957
| +63% | +$1.07M | 0.01% | 582 |
|
|
2013
Q3 | $1.59M | Sell |
25,345
-472
| -2% | -$29.6K | 0.01% | 594 |
|
|
2013
Q2 | $1.61K | Buy |
+25,817
| New | +$1.61K | 0.01% | 574 |
|